ETHYL ALCOHOL

ETHYL ALCOHOL was reported 27574 times

ETHYL ALCOHOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ALCOHOLIC COMA 9 0.5294
1 EX-DRUG ABUSER 13 0.4815
2 BLOOD ETHANOL 18 0.4286
3 POSTMORTEM BLOOD DRUG LEVEL 21 0.3559
4 ALCOHOL INTERACTION 579 0.2977
5 VICTIM OF CRIME 354 0.2862
6 ALCOHOL TEST POSITIVE 13 0.2766
7 POSTMORTEM BLOOD DRUG LEVEL ABNORMAL 36 0.2449
8 CHEMICAL SUBMISSION 59 0.2332
9 BEHAVIOURAL ADDICTION 14 0.2222
10 BRACHIAL ARTERY ENTRAPMENT SYNDROME 8 0.2105
11 ALCOHOL ABUSE 515 0.1924
12 FOETAL ALCOHOL SYNDROME 18 0.1800
13 ALCOHOL POISONING 449 0.1675
14 BLOOD ALCOHOL INCREASED 120 0.1533
15 SUBSTANCE USE DISORDER 440 0.1380
16 FATTY LIVER ALCOHOLIC 8 0.1379
17 BLOOD ETHANOL INCREASED 30 0.1364
18 POLYSUBSTANCE DEPENDENCE 23 0.1345
19 SUSPECTED SUICIDE 607 0.1294
20 SUBSTANCE DEPENDENCE 83 0.1233
21 VICTIM OF SEXUAL ABUSE 61 0.1160
22 EXPOSURE TO TOXIC AGENT 336 0.1049
23 SUBSTANCE ABUSE 846 0.1038
24 ABDOMINAL WALL ANOMALY 9 0.1011
25 ILLICIT PRESCRIPTION ATTAINMENT 12 0.1000
26 ALCOHOLIC 19 0.0955
27 ALCOHOL WITHDRAWAL SYNDROME 73 0.0839
28 ALCOHOL USE DISORDER 14 0.0819
29 HANGING 16 0.0808
30 INDUCED ABORTION FAILED 10 0.0763
31 HOMICIDE 140 0.0759
32 ALCOHOL USE 279 0.0755
33 POSTMORTEM BLOOD DRUG LEVEL INCREASED 28 0.0751
34 ADULTERATED PRODUCT 15 0.0750
35 SUBSTANCE ABUSER 17 0.0749
36 CHILD NEGLECT 18 0.0747
37 OPIATES POSITIVE 35 0.0729
38 COMPLETED SUICIDE 5458 0.0654
39 ALCOHOL PROBLEM 16 0.0653
40 VICTIM OF HOMICIDE 38 0.0653
41 DRUG ABUSE 5386 0.0646
42 SEXUAL ABUSE 28 0.0632
43 TOXICOLOGIC TEST ABNORMAL 36 0.0594
44 ALCOHOL INTOLERANCE 42 0.0592
45 LABELLED DRUG-FOOD INTERACTION ISSUE 10 0.0588
46 VICTIM OF CHEMICAL SUBMISSION 39 0.0581
47 CONGESTIVE HEPATOPATHY 26 0.0580
48 BREATH ALCOHOL TEST POSITIVE 13 0.0578
49 DRUG USE DISORDER 484 0.0575
50 SLEEP WALKING 30 0.0521
51 ALCOHOLIC PANCREATITIS 10 0.0513
52 DEXTROCARDIA 9 0.0479
53 MULTIPLE DRUG OVERDOSE INTENTIONAL 152 0.0472
54 DELIRIUM TREMENS 19 0.0470
55 CHILD ABUSE 12 0.0463
56 ACCIDENTAL DEATH 82 0.0441
57 VISCERAL CONGESTION 21 0.0411
58 PHYSICAL ASSAULT 81 0.0387
59 POISONING DELIBERATE 366 0.0386
60 BIRTH MARK 8 0.0385
61 ALCOHOLIC LIVER DISEASE 13 0.0383
62 STAB WOUND 13 0.0367
63 TOXICITY TO VARIOUS AGENTS 6130 0.0363
64 CONGENITAL UMBILICAL HERNIA 13 0.0349
65 CRIME 9 0.0341
66 ALCOHOLISM 145 0.0338
67 CARDIO-RESPIRATORY ARREST 1350 0.0323
68 DETOXIFICATION 11 0.0318
69 HEPATITIS ALCOHOLIC 10 0.0306
70 CIRRHOSIS ALCOHOLIC 14 0.0306
71 GUN SHOT WOUND 57 0.0300
72 POISONING 370 0.0294
73 CENTRAL NERVOUS SYSTEM NECROSIS 8 0.0291
74 SUSPECTED SUICIDE ATTEMPT 17 0.0285
75 ASPHYXIA 229 0.0280
76 DRUG DETOXIFICATION 25 0.0280
77 BRADYPNOEA 75 0.0278
78 LEGAL PROBLEM 20 0.0271
79 MIOSIS 218 0.0271
80 AMPHETAMINES POSITIVE 20 0.0267
81 DRUG SCREEN POSITIVE 209 0.0264
82 MYOCARDIAL FIBROSIS 22 0.0262
83 IMPAIRED DRIVING ABILITY 295 0.0259
84 INTENTIONAL OVERDOSE 1574 0.0245
85 SENSORIMOTOR DISORDER 12 0.0241
86 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 18 0.0231
87 SUICIDE ATTEMPT 1393 0.0230
88 SELF INJURIOUS BEHAVIOUR 69 0.0226
89 THEFT 15 0.0226
90 INTENTIONAL MISUSE 43 0.0225
91 ACCIDENTAL POISONING 30 0.0219
92 DROWNING 22 0.0217
93 RESPIRATORY DEPRESSION 263 0.0214
94 ANALGESIC DRUG LEVEL INCREASED 34 0.0212
95 ANISOCORIA 8 0.0212
96 PATIENT UNCOOPERATIVE 10 0.0211
97 HYPERLIPASAEMIA 11 0.0210
98 JUDGEMENT IMPAIRED 30 0.0206
99 CARDIOVASCULAR SYMPTOM 8 0.0206
100 MULTIPLE DRUG OVERDOSE 102 0.0205
101 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 99 0.0193
102 DRUG DIVERSION 119 0.0192
103 COUNTERFEIT PRODUCT ADMINISTERED 25 0.0192
104 CARDIAC DEATH 23 0.0190
105 MYDRIASIS 244 0.0190
106 ANION GAP 12 0.0189
107 RESPIRATORY ARREST 522 0.0189
108 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 116 0.0188
109 SUBSTANCE USE 29 0.0186
110 COMA 882 0.0185
111 VERBAL ABUSE 9 0.0184
112 PARASOMNIA 13 0.0181
113 PRODUCT ADMINISTRATION INTERRUPTED 142 0.0181
114 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 9 0.0180
115 BEZOAR 24 0.0174
116 CARDIAC HYPERTROPHY 19 0.0170
117 COMA SCALE ABNORMAL 49 0.0169
118 AREFLEXIA 45 0.0168
119 DISINHIBITION 27 0.0168
120 IMPRISONMENT 29 0.0164
121 SOMNAMBULISM 106 0.0161
122 NON-CARDIOGENIC PULMONARY OEDEMA 17 0.0161
123 RESPIRATORY ACIDOSIS 63 0.0160
124 TOXIC LEUKOENCEPHALOPATHY 11 0.0152
125 ABNORMAL SLEEP-RELATED EVENT 20 0.0151
126 GRIEF REACTION 8 0.0151
127 SLEEP-RELATED EATING DISORDER 14 0.0149
128 EUPHORIC MOOD 151 0.0147
129 FEELING OF RELAXATION 10 0.0146
130 PUPIL FIXED 25 0.0144
131 BEHAVIOUR DISORDER 75 0.0139
132 POTENTIATING DRUG INTERACTION 45 0.0134
133 SOPOR 177 0.0133
134 PILOERECTION 14 0.0128
135 BRAIN DEATH 39 0.0126
136 HYPOTHERMIA 127 0.0125
137 FOAMING AT MOUTH 25 0.0124
138 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 41 0.0124
139 ARTERIAL INJURY 9 0.0120
140 AGGRESSION 598 0.0119
141 DISTRIBUTIVE SHOCK 27 0.0119
142 PSYCHOTIC BEHAVIOUR 12 0.0118
143 PULSELESS ELECTRICAL ACTIVITY 49 0.0117
144 DEREALISATION 25 0.0116
145 SUICIDAL BEHAVIOUR 48 0.0115
146 CONSCIOUSNESS FLUCTUATING 12 0.0115
147 HYPOPERFUSION 12 0.0114
148 BORDERLINE PERSONALITY DISORDER 8 0.0113
149 HEPATIC FIBROSIS 38 0.0111
150 BRAIN HYPOXIA 11 0.0109
151 BRAIN STEM SYNDROME 8 0.0107
152 TOOTH EROSION 13 0.0106
153 ALLERGY TO CHEMICALS 13 0.0104
154 NYSTAGMUS 55 0.0104
155 NEOPLASM SKIN 16 0.0103
156 INTENTIONAL SELF-INJURY 208 0.0103
157 DRUG TOLERANCE INCREASED 8 0.0102
158 BLADDER DILATATION 11 0.0101
159 DRUG ABUSER 62 0.0101
160 INTENTIONAL PRODUCT MISUSE 874 0.0100
161 TEARFULNESS 42 0.0098
162 ALTERED STATE OF CONSCIOUSNESS 210 0.0097
163 DRUG TOXICITY 132 0.0097
164 ACIDOSIS 74 0.0097
165 PERSONALITY DISORDER 25 0.0095
166 HEPATIC CONGESTION 9 0.0095
167 ARTERIOSCLEROSIS CORONARY ARTERY 63 0.0095
168 MACROCYTOSIS 11 0.0095
169 ROAD TRAFFIC ACCIDENT 395 0.0094
170 BRAIN OEDEMA 119 0.0094
171 ANTICHOLINERGIC SYNDROME 15 0.0094
172 DEPRESSED LEVEL OF CONSCIOUSNESS 371 0.0094
173 ACUTE HEPATIC FAILURE 128 0.0094
174 PRODUCT COUNTERFEIT 16 0.0093
175 PSYCHOMOTOR SKILLS IMPAIRED 24 0.0092
176 CARDIAC ARREST 755 0.0091
177 ASPIRATION 100 0.0091
178 GASTRIC DILATATION 15 0.0090
179 OVERDOSE 1936 0.0090
180 AMNESIA 582 0.0089
181 HEPATIC ENCEPHALOPATHY 82 0.0088
182 DRUG TOLERANCE 44 0.0087
183 HYPERLACTACIDAEMIA 23 0.0086
184 CELL DEATH 17 0.0086
185 INTELLECTUAL DISABILITY 13 0.0086
186 BLOOD LACTIC ACID INCREASED 45 0.0085
187 COMPARTMENT SYNDROME 22 0.0084
188 ELECTROCARDIOGRAM CHANGE 8 0.0084
189 SINUS TACHYCARDIA 119 0.0084
190 EXPOSURE VIA INGESTION 21 0.0083
191 EXTRADURAL HAEMATOMA 11 0.0083
192 LABELLED DRUG-DRUG INTERACTION ISSUE 12 0.0083
193 LOGORRHOEA 29 0.0082
194 ANION GAP INCREASED 11 0.0082
195 HEPATIC NECROSIS 31 0.0082
196 GENERALISED ANXIETY DISORDER 12 0.0082
197 COMPLEX PARTIAL SEIZURES 9 0.0081
198 UNRESPONSIVE TO STIMULI 208 0.0081
199 ANTISOCIAL BEHAVIOUR 8 0.0080
200 DRUG LEVEL INCREASED 132 0.0080
201 HANGOVER 28 0.0080
202 AGITATION 583 0.0079
203 HOMICIDAL IDEATION 31 0.0076
204 RESPIRATORY RATE DECREASED 24 0.0076
205 OBSTRUCTIVE SLEEP APNOEA SYNDROME 11 0.0075
206 HYPERTENSIVE HEART DISEASE 14 0.0075
207 HYPERREFLEXIA 26 0.0075
208 SEDATION COMPLICATION 19 0.0074
209 ARTERIOSCLEROSIS 70 0.0074
210 BINGE EATING 8 0.0074
211 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 8 0.0074
212 BREATH ODOUR 18 0.0074
213 RESPIRATORY ALKALOSIS 12 0.0074
214 PNEUMONIA ASPIRATION 184 0.0074
215 CLUSTER HEADACHE 10 0.0073
216 BRADYARRHYTHMIA 12 0.0073
217 PERSECUTORY DELUSION 18 0.0072
218 PRE-EXISTING CONDITION IMPROVED 45 0.0072
219 PSYCHIATRIC DECOMPENSATION 14 0.0072
220 PSYCHOMOTOR RETARDATION 20 0.0071
221 SOCIAL AVOIDANT BEHAVIOUR 41 0.0071
222 HYPOVENTILATION 23 0.0071
223 METABOLIC ACIDOSIS 224 0.0070
224 TONIC CLONIC MOVEMENTS 9 0.0069
225 SINUS ARRHYTHMIA 9 0.0069
226 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 18 0.0069
227 DYSARTHRIA 258 0.0068
228 SELF-MEDICATION 28 0.0068
229 FOOD INTERACTION 12 0.0068
230 INCOHERENT 44 0.0068
231 DISTURBANCE IN SOCIAL BEHAVIOUR 16 0.0068
232 SKULL FRACTURE 11 0.0068
233 RENAL TUBULAR NECROSIS 66 0.0067
234 SLOW SPEECH 16 0.0066
235 TACHYCARDIA 585 0.0066
236 MYOCARDITIS 75 0.0065
237 SEROTONIN SYNDROME 125 0.0065
238 DAYDREAMING 10 0.0065
239 ABNORMAL BEHAVIOUR 257 0.0065
240 DRUG WITHDRAWAL SYNDROME NEONATAL 96 0.0065
241 PUPILLARY REFLEX IMPAIRED 12 0.0065
242 SLEEP TALKING 11 0.0065
243 ELECTROCARDIOGRAM QT PROLONGED 233 0.0065
244 MAJOR DEPRESSION 47 0.0064
245 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 110 0.0064
246 ANTIPSYCHOTIC DRUG LEVEL INCREASED 18 0.0064
247 VENTRICULAR HYPERTROPHY 16 0.0064
248 HOSTILITY 16 0.0063
249 EYE CONTUSION 13 0.0061
250 SHOCK 141 0.0061
251 SUICIDAL IDEATION 560 0.0061
252 VASOPLEGIA SYNDROME 10 0.0061
253 ACCIDENTAL OVERDOSE 223 0.0061
254 GRAND MAL CONVULSION 56 0.0061
255 PARANOIA 104 0.0060
256 EDUCATIONAL PROBLEM 10 0.0060
257 CEREBELLAR SYNDROME 13 0.0059
258 LIBIDO INCREASED 12 0.0059
259 PULMONARY CONGESTION 78 0.0059
260 CEREBELLAR INFARCTION 10 0.0059
261 CLONUS 16 0.0058
262 DRUG DEPENDENCE 940 0.0058
263 IMPULSE-CONTROL DISORDER 12 0.0058
264 PULMONARY OEDEMA 261 0.0058
265 POST-TRAUMATIC STRESS DISORDER 39 0.0058
266 DRUG INTERACTION 917 0.0058
267 SUDDEN DEATH 61 0.0058
268 LIVER INJURY 141 0.0057
269 SELF-INJURIOUS IDEATION 24 0.0057
270 CARDIOGENIC SHOCK 82 0.0057
271 HEPATIC STEATOSIS 105 0.0056
272 CRANIOCEREBRAL INJURY 17 0.0056
273 IMPULSIVE BEHAVIOUR 21 0.0056
274 LOSS OF CONSCIOUSNESS 717 0.0056
275 DRUG LEVEL ABOVE THERAPEUTIC 25 0.0055
276 HEPATOMEGALY 53 0.0054
277 BRAIN INJURY 54 0.0054
278 BRAIN HERNIATION 16 0.0054
279 HEPATORENAL SYNDROME 9 0.0053
280 STUPOR 17 0.0053
281 ENURESIS 21 0.0052
282 TACHYPHRENIA 18 0.0052
283 CLEFT PALATE 10 0.0052
284 CONVERSION DISORDER 10 0.0051
285 CLUMSINESS 14 0.0051
286 DRUG WITHDRAWAL CONVULSIONS 9 0.0051
287 GENERALISED TONIC-CLONIC SEIZURE 82 0.0050
288 HEPATIC CIRRHOSIS 93 0.0049
289 VENTRICULAR ARRHYTHMIA 18 0.0049
290 CONDUCTION DISORDER 9 0.0049
291 APNOEA 38 0.0049
292 CARDIOMEGALY 60 0.0049
293 RHABDOMYOLYSIS 203 0.0049
294 RESTLESSNESS 177 0.0048
295 SOMNOLENCE 971 0.0048
296 INTERVERTEBRAL DISCITIS 9 0.0048
297 FLAT AFFECT 11 0.0047
298 SCREAMING 30 0.0047
299 CIRCULATORY COLLAPSE 80 0.0047
300 ENCEPHALOPATHY 115 0.0047
301 BLOOD PH DECREASED 8 0.0047
302 INTENTIONAL DOSE OMISSION 133 0.0047
303 URINARY TRACT OBSTRUCTION 11 0.0046
304 LEFT VENTRICULAR DYSFUNCTION 31 0.0046
305 CARDIOPULMONARY FAILURE 18 0.0046
306 NASAL SEPTUM DEVIATION 9 0.0046
307 MULTIPLE INJURIES 29 0.0046
308 SOCIAL PROBLEM 19 0.0046
309 HEPATIC FAILURE 138 0.0046
310 DELIRIUM 158 0.0045
311 HYPERTONIA 26 0.0045
312 MYOCLONUS 54 0.0045
313 CYANOSIS 71 0.0045
314 SNORING 17 0.0045
315 CONTRAINDICATED PRODUCT ADMINISTERED 136 0.0045
316 EJACULATION FAILURE 9 0.0045
317 PULMONARY HAEMORRHAGE 35 0.0045
318 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 10 0.0045
319 DRUG WITHDRAWAL SYNDROME 392 0.0045
320 FACIAL BONES FRACTURE 16 0.0044
321 FEELING DRUNK 33 0.0044
322 INJECTION SITE ABSCESS 11 0.0044
323 INTENTIONAL PRODUCT USE ISSUE 383 0.0044
324 TONGUE BITING 9 0.0044
325 HEPATOTOXICITY 96 0.0043
326 INTENTIONAL DRUG MISUSE 90 0.0043
327 ENDOTRACHEAL INTUBATION 12 0.0043
328 LEFT VENTRICULAR HYPERTROPHY 18 0.0042
329 HAEMODYNAMIC INSTABILITY 32 0.0042
330 WITHDRAWAL SYNDROME 176 0.0042
331 PROTHROMBIN TIME PROLONGED 25 0.0042
332 HYPOREFLEXIA 8 0.0042
333 DISORIENTATION 165 0.0042
334 VENTRICULAR TACHYCARDIA 68 0.0041
335 ACUTE PULMONARY OEDEMA 23 0.0041
336 MULTI-ORGAN DISORDER 8 0.0041
337 PSYCHOTIC DISORDER 119 0.0040
338 LEUKOENCEPHALOPATHY 15 0.0040
339 DEPRESSIVE SYMPTOM 14 0.0040
340 PSYCHOMOTOR HYPERACTIVITY 65 0.0039
341 BLOOD CREATINE PHOSPHOKINASE INCREASED 112 0.0039
342 NEUROLOGICAL DECOMPENSATION 9 0.0039
343 METHAEMOGLOBINAEMIA 9 0.0039
344 BIPOLAR DISORDER 42 0.0039
345 FEELING OF DESPAIR 18 0.0039
346 ACCIDENT 46 0.0038
347 DILATATION VENTRICULAR 8 0.0038
348 LACTIC ACIDOSIS 123 0.0038
349 ATAXIA 45 0.0038
350 FUNCTIONAL GASTROINTESTINAL DISORDER 13 0.0038
351 HYPOPNOEA 13 0.0037
352 SLUGGISHNESS 38 0.0037
353 BLOOD SODIUM INCREASED 10 0.0037
354 HYPERTHERMIA 28 0.0037
355 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 8 0.0036
356 PARTIAL SEIZURES 19 0.0036
357 COAGULOPATHY 60 0.0036
358 PULSE ABSENT 17 0.0036
359 EXCORIATION 9 0.0035
360 MENTAL STATUS CHANGES 98 0.0035
361 APATHY 51 0.0035
362 DRUG TITRATION ERROR 9 0.0035
363 CARDIAC FAILURE ACUTE 23 0.0034
364 VENTRICULAR FIBRILLATION 38 0.0034
365 DELUSION 53 0.0034
366 MANIA 56 0.0034
367 DISSOCIATION 26 0.0034
368 RESPIRATION ABNORMAL 23 0.0033
369 PERSONALITY CHANGE 31 0.0033
370 PANIC REACTION 24 0.0033
371 ATTENTION DEFICIT HYPERACTIVITY DISORDER 14 0.0033
372 MULTIPLE ORGAN DYSFUNCTION SYNDROME 93 0.0033
373 HYPOMANIA 12 0.0033
374 SEDATION 85 0.0032
375 HYPOXIA 114 0.0032
376 ACUTE RESPIRATORY FAILURE 62 0.0032
377 HYPERAMMONAEMIA 16 0.0032
378 DRUG-INDUCED LIVER INJURY 99 0.0032
379 HYPOTENSION 632 0.0031
380 SEIZURE 361 0.0031
381 HAEMOTHORAX 9 0.0031
382 HYPOGLYCAEMIA 150 0.0031
383 HALLUCINATION, AUDITORY 49 0.0031
384 HEPATITIS ACUTE 20 0.0031
385 BRADYPHRENIA 20 0.0031
386 OLIGURIA 19 0.0031
387 THINKING ABNORMAL 57 0.0031
388 BUNDLE BRANCH BLOCK RIGHT 14 0.0030
389 INTENTIONAL UNDERDOSE 22 0.0030
390 SALIVARY HYPERSECRETION 30 0.0030
391 HALLUCINATION, VISUAL 63 0.0030
392 LOSS OF EMPLOYMENT 9 0.0030
393 CEREBRAL HAEMATOMA 10 0.0030
394 TENSION 18 0.0030
395 ANORGASMIA 8 0.0029
396 HYPERVENTILATION 17 0.0029
397 FAMILY STRESS 9 0.0029
398 ACUTE RESPIRATORY DISTRESS SYNDROME 51 0.0029
399 BRADYKINESIA 17 0.0029
400 EMPHYSEMA 29 0.0029
401 NON-CARDIAC CHEST PAIN 9 0.0028
402 CONCUSSION 22 0.0028
403 THROMBOTIC THROMBOCYTOPENIC PURPURA 10 0.0028
404 BUNDLE BRANCH BLOCK LEFT 12 0.0028
405 VENTRICULAR HYPOKINESIA 9 0.0028
406 DEVELOPMENTAL DELAY 25 0.0028
407 PRODUCT ADMINISTRATION ERROR 56 0.0028
408 MEDICATION ERROR 154 0.0028
409 HEAD INJURY 87 0.0027
410 ANGER 92 0.0027
411 SCHIZOPHRENIA 33 0.0027
412 GAMMA-GLUTAMYLTRANSFERASE INCREASED 60 0.0027
413 ANXIETY DISORDER 9 0.0027
414 CONVULSION 154 0.0027
415 ELECTROCARDIOGRAM ABNORMAL 21 0.0027
416 HEPATIC CYTOLYSIS 34 0.0027
417 TRANSAMINASES INCREASED 59 0.0027
418 CONGESTIVE CARDIOMYOPATHY 11 0.0026
419 MYOCARDIAL ISCHAEMIA 30 0.0026
420 HALLUCINATIONS, MIXED 11 0.0026
421 HAEMOLYSIS 20 0.0026
422 METABOLIC DISORDER 15 0.0026
423 GASTRITIS EROSIVE 12 0.0026
424 TACHYPNOEA 35 0.0026
425 ABNORMAL DREAMS 71 0.0026
426 MENTAL IMPAIRMENT 62 0.0026
427 SUBARACHNOID HAEMORRHAGE 26 0.0026
428 CONFUSIONAL STATE 412 0.0025
429 PETIT MAL EPILEPSY 13 0.0025
430 HYPOKALAEMIA 117 0.0025
431 HALLUCINATION 188 0.0025
432 LEUKOCYTOSIS 45 0.0025
433 ORGAN FAILURE 10 0.0025
434 EJECTION FRACTION DECREASED 38 0.0024
435 DRUG ADMINISTRATION ERROR 75 0.0024
436 DEPRESSED MOOD 129 0.0024
437 COORDINATION ABNORMAL 34 0.0024
438 PAPULE 17 0.0024
439 MENTAL DISORDER 105 0.0024
440 ELECTROLYTE IMBALANCE 28 0.0024
441 HEPATITIS C 29 0.0024
442 THERMAL BURN 17 0.0024
443 STATUS EPILEPTICUS 27 0.0024
444 AFFECT LABILITY 23 0.0024
445 HEPATITIS 61 0.0024
446 HAEMODIALYSIS 20 0.0024
447 NEPHROGENIC ANAEMIA 11 0.0024
448 DECREASED INTEREST 14 0.0024
449 ENERGY INCREASED 14 0.0024
450 NIGHTMARE 82 0.0024
451 TOXIC ENCEPHALOPATHY 12 0.0024
452 SLEEP APNOEA SYNDROME 45 0.0024
453 DEPRESSION SUICIDAL 8 0.0023
454 TORSADE DE POINTES 18 0.0023
455 AFFECTIVE DISORDER 18 0.0023
456 BRADYCARDIA 121 0.0023
457 DISSEMINATED INTRAVASCULAR COAGULATION 32 0.0023
458 CONCOMITANT DISEASE AGGRAVATED 14 0.0023
459 TREATMENT NONCOMPLIANCE 124 0.0023
460 BRUXISM 12 0.0022
461 SKIN LACERATION 24 0.0022
462 LIVER FUNCTION TEST ABNORMAL 64 0.0022
463 LIVER TRANSPLANT 8 0.0022
464 AKATHISIA 30 0.0022
465 ARTHRITIS BACTERIAL 9 0.0022
466 LETHARGY 125 0.0022
467 FORMICATION 15 0.0022
468 INTRACRANIAL PRESSURE INCREASED 12 0.0022
469 RESPIRATORY RATE INCREASED 19 0.0021
470 OXYGEN SATURATION DECREASED 119 0.0021
471 HYPOTONIA 21 0.0021
472 IRRITABILITY 126 0.0021
473 ATRIOVENTRICULAR BLOCK FIRST DEGREE 9 0.0021
474 RESTLESS LEGS SYNDROME 37 0.0020
475 ALANINE AMINOTRANSFERASE INCREASED 124 0.0020
476 FACE OEDEMA 34 0.0020
477 HEPATIC ENZYME ABNORMAL 10 0.0020
478 DISTURBANCE IN ATTENTION 108 0.0020
479 CORONARY ARTERY STENOSIS 10 0.0020
480 VASCULAR DEVICE INFECTION 9 0.0020
481 MOOD SWINGS 63 0.0020
482 FOETAL GROWTH RESTRICTION 12 0.0020
483 COGNITIVE DISORDER 92 0.0020
484 DEPRESSION 445 0.0020
485 NEUTROPHIL COUNT INCREASED 20 0.0020
486 POOR QUALITY SLEEP 42 0.0019
487 INJURY 134 0.0019
488 CARDIOTOXICITY 17 0.0019
489 CATATONIA 10 0.0019
490 FOOD CRAVING 10 0.0019
491 PSYCHIATRIC SYMPTOM 14 0.0019
492 DRUG EXPOSURE DURING PREGNANCY 64 0.0019
493 DEATH 1616 0.0019
494 HYPERTRANSAMINASAEMIA 13 0.0019
495 HYPOKINESIA 27 0.0019
496 ASPARTATE AMINOTRANSFERASE INCREASED 98 0.0018
497 DERMATITIS CONTACT 21 0.0018
498 MUSCLE TWITCHING 42 0.0018
499 HYPERVOLAEMIA 9 0.0018
500 MIDDLE INSOMNIA 34 0.0018
501 INCORRECT ROUTE OF DRUG ADMINISTRATION 65 0.0018
502 GASTROINTESTINAL SOUNDS ABNORMAL 9 0.0018
503 LACERATION 17 0.0018
504 ACUTE KIDNEY INJURY 276 0.0018
505 DYSPHORIA 9 0.0018
506 NERVOUS SYSTEM DISORDER 55 0.0018
507 MOOD ALTERED 48 0.0018
508 BLOOD PRESSURE SYSTOLIC DECREASED 8 0.0018
509 ISCHAEMIA 8 0.0017
510 SURGERY 102 0.0017
511 PANIC ATTACK 63 0.0017
512 HUNGER 24 0.0017
513 EMOTIONAL DISORDER 53 0.0017
514 FEELING OF BODY TEMPERATURE CHANGE 10 0.0017
515 CRYING 62 0.0017
516 ANXIETY 484 0.0017
517 TREMOR 281 0.0017
518 LIVE BIRTH 14 0.0017
519 ARRHYTHMIA 79 0.0017
520 MOTOR DYSFUNCTION 17 0.0017
521 ANAL INCONTINENCE 15 0.0017
522 INITIAL INSOMNIA 17 0.0017
523 ANOREXIA 21 0.0016
524 ANURIA 14 0.0016
525 KNEE OPERATION 16 0.0016
526 BREATH SOUNDS ABNORMAL 8 0.0016
527 HAEMATEMESIS 41 0.0016
528 HYSTERECTOMY 14 0.0016
529 CHOLESTASIS 31 0.0016
530 ABDOMINAL TENDERNESS 8 0.0016
531 HYPERNATRAEMIA 8 0.0016
532 HYPERHIDROSIS 206 0.0016
533 EATING DISORDER 34 0.0016
534 POLYURIA 13 0.0016
535 FOETAL EXPOSURE DURING PREGNANCY 127 0.0016
536 ERECTILE DYSFUNCTION 40 0.0016
537 PANCREATITIS ACUTE 35 0.0016
538 SINUS BRADYCARDIA 15 0.0016
539 SPINAL OPERATION 19 0.0015
540 LIP DRY 14 0.0015
541 VENTRICULAR EXTRASYSTOLES 16 0.0015
542 FACIAL PARALYSIS 13 0.0015
543 RESPIRATORY DISTRESS 42 0.0015
544 NEUROLEPTIC MALIGNANT SYNDROME 18 0.0015
545 MULTI-ORGAN FAILURE 26 0.0015
546 LEARNING DISABILITY 8 0.0015
547 GASTROINTESTINAL MOTILITY DISORDER 8 0.0015
548 ABORTION INDUCED 14 0.0015
549 RENAL FAILURE ACUTE 63 0.0015
550 HEPATOCELLULAR INJURY 21 0.0015
551 BLOOD BILIRUBIN INCREASED 40 0.0015
552 VOMITING 696 0.0015
553 PARALYSIS 21 0.0015
554 HYPERSOMNIA 42 0.0015
555 EYE MOVEMENT DISORDER 10 0.0015
556 RESPIRATORY FAILURE 106 0.0015
557 SPLENOMEGALY 17 0.0014
558 EPILEPSY 44 0.0014
559 MATERNAL DRUGS AFFECTING FOETUS 11 0.0014
560 ATRIAL SEPTAL DEFECT 12 0.0014
561 ATRIOVENTRICULAR BLOCK 11 0.0014
562 MEMORY IMPAIRMENT 195 0.0014
563 PANCREATITIS 75 0.0014
564 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
565 APHASIA 42 0.0014
566 PERICARDIAL EFFUSION 32 0.0014
567 HYPOVOLAEMIA 8 0.0014
568 HYPERTRIGLYCERIDAEMIA 8 0.0014
569 SENSORY LOSS 11 0.0014
570 SEXUAL DYSFUNCTION 16 0.0014
571 DENTAL CARIES 15 0.0014
572 OBSTRUCTIVE AIRWAYS DISORDER 15 0.0013
573 HYPERLIPIDAEMIA 16 0.0013
574 FEAR 36 0.0013
575 SUBDURAL HAEMATOMA 19 0.0013
576 BODY TEMPERATURE DECREASED 13 0.0013
577 NOCTURIA 16 0.0013
578 SLEEP DISORDER 93 0.0013
579 SKIN PLAQUE 11 0.0013
580 BACK INJURY 14 0.0013
581 THIRST 23 0.0013
582 SEASONAL ALLERGY 18 0.0013
583 OBESITY 20 0.0013
584 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
585 BLOOD ALKALINE PHOSPHATASE INCREASED 31 0.0012
586 ATELECTASIS 12 0.0012
587 PRESCRIBED OVERDOSE 24 0.0012
588 CARDIAC FLUTTER 8 0.0012
589 MITRAL VALVE INCOMPETENCE 14 0.0012
590 HIATUS HERNIA 16 0.0012
591 VITAMIN D DEFICIENCY 12 0.0012
592 INTERNATIONAL NORMALISED RATIO INCREASED 35 0.0012
593 WHITE BLOOD CELL COUNT INCREASED 47 0.0012
594 JOINT INJURY 26 0.0012
595 WRONG TECHNIQUE IN DRUG USAGE PROCESS 44 0.0012
596 HEPATIC ENZYME INCREASED 82 0.0012
597 BALANCE DISORDER 103 0.0012
598 BRONCHOSPASM 17 0.0012
599 JAUNDICE 32 0.0012
600 FOOD ALLERGY 9 0.0012
601 PERIPHERAL COLDNESS 16 0.0012
602 DISABILITY 23 0.0012
603 ANKLE FRACTURE 18 0.0012
604 HYPERBILIRUBINAEMIA 12 0.0012
605 HYPERGLYCAEMIA 42 0.0012
606 HEPATIC FUNCTION ABNORMAL 43 0.0012
607 HYPOMAGNESAEMIA 16 0.0011
608 URINARY RETENTION 38 0.0011
609 HYPERTENSION 239 0.0011
610 ATRIAL FLUTTER 9 0.0011
611 INSOMNIA 299 0.0011
612 WRONG DRUG ADMINISTERED 10 0.0011
613 QUALITY OF LIFE DECREASED 15 0.0011
614 BLOOD SODIUM DECREASED 21 0.0011
615 URINARY INCONTINENCE 33 0.0011
616 HEART RATE DECREASED 39 0.0011
617 NERVOUSNESS 58 0.0011
618 LIMB INJURY 30 0.0011
619 FEELING JITTERY 21 0.0011
620 HEART RATE INCREASED 109 0.0011
621 INTERVERTEBRAL DISC PROTRUSION 24 0.0011
622 PREMATURE BABY 33 0.0011
623 HYPERAESTHESIA 9 0.0011
624 LOWER LIMB FRACTURE 21 0.0011
625 ATRIAL FIBRILLATION 106 0.0011
626 SPEECH DISORDER 57 0.0011
627 DYSTONIA 21 0.0011
628 DYSKINESIA 44 0.0011
629 CARDIOMYOPATHY 16 0.0011
630 LIVER DISORDER 48 0.0011
631 FALL 360 0.0011
632 BLOOD TRIGLYCERIDES INCREASED 19 0.0011
633 PNEUMOTHORAX 17 0.0011
634 OCULAR DISCOMFORT 12 0.0011
635 PALLOR 29 0.0011
636 HEMIPARESIS 18 0.0011
637 BLOOD PRESSURE DECREASED 70 0.0011
638 PRODUCT USE ISSUE 197 0.0010
639 SCRATCH 11 0.0010
640 INCONTINENCE 11 0.0010
641 UNEVALUABLE EVENT 78 0.0010
642 URINE OUTPUT DECREASED 9 0.0010
643 IMPAIRED WORK ABILITY 22 0.0010
644 HYPERKALAEMIA 36 0.0010
645 PRODUCT PREPARATION ERROR 21 0.0010
646 DEPENDENCE 56 0.0010
647 CARDIAC FAILURE 82 0.0010
648 BLOOD CHOLESTEROL INCREASED 47 0.0010
649 ABSCESS 16 0.0010
650 EXPOSURE DURING PREGNANCY 62 0.0010
651 HYPONATRAEMIA 56 0.0010
652 SCAR 17 0.0010
653 CORONARY ARTERY DISEASE 30 0.0010
654 NERVE INJURY 11 0.0010
655 BEDRIDDEN 13 0.0010
656 MUSCULOSKELETAL DISCOMFORT 17 0.0010
657 NERVE COMPRESSION 9 0.0010
658 OCULAR HYPERAEMIA 46 0.0010
659 EXTRAPYRAMIDAL DISORDER 24 0.0010
660 WOUND 27 0.0010
661 DRY MOUTH 78 0.0010
662 THERAPEUTIC RESPONSE UNEXPECTED 43 0.0010
663 PHOTOPHOBIA 18 0.0010
664 PLEURAL EFFUSION 58 0.0010
665 DYSURIA 35 0.0009
666 BLOOD LACTATE DEHYDROGENASE INCREASED 15 0.0009
667 CHOLELITHIASIS 31 0.0009
668 MATERNAL EXPOSURE DURING PREGNANCY 84 0.0009
669 HYPERCHOLESTEROLAEMIA 9 0.0009
670 BLOOD POTASSIUM DECREASED 28 0.0009
671 NIGHT SWEATS 30 0.0009
672 CHROMATURIA 21 0.0009
673 ACCIDENTAL EXPOSURE TO PRODUCT 95 0.0009
674 PHARYNGEAL SWELLING 9 0.0009
675 SYNCOPE 91 0.0009
676 TUBULOINTERSTITIAL NEPHRITIS 17 0.0009
677 FEELING ABNORMAL 217 0.0009
678 BLOOD UREA INCREASED 15 0.0009
679 BLOOD URINE PRESENT 17 0.0009
680 RENAL FAILURE 118 0.0009
681 HERNIA 17 0.0009
682 END STAGE RENAL DISEASE 16 0.0009
683 RIB FRACTURE 18 0.0009
684 GASTRITIS 23 0.0009
685 VERTIGO 53 0.0009
686 MUSCLE TIGHTNESS 14 0.0009
687 DERMATITIS 18 0.0009
688 CARPAL TUNNEL SYNDROME 12 0.0009
689 DIARRHOEA HAEMORRHAGIC 8 0.0009
690 RETCHING 18 0.0008
691 POLLAKIURIA 35 0.0008
692 EYE INFLAMMATION 8 0.0008
693 INCREASED APPETITE 16 0.0008
694 GOUT 15 0.0008
695 RESPIRATORY DISORDER 25 0.0008
696 DECREASED ACTIVITY 9 0.0008
697 BLOOD CREATININE INCREASED 54 0.0008
698 DIZZINESS POSTURAL 8 0.0008
699 ABORTION SPONTANEOUS 33 0.0008
700 TOOTH FRACTURE 9 0.0008
701 LIGAMENT SPRAIN 8 0.0008
702 IMPAIRED GASTRIC EMPTYING 11 0.0008
703 MALNUTRITION 9 0.0008
704 TOOTH EXTRACTION 10 0.0008
705 CONTUSION 77 0.0008
706 SECRETION DISCHARGE 10 0.0008
707 PARAESTHESIA 125 0.0008
708 FOOT FRACTURE 15 0.0008
709 STAPHYLOCOCCAL INFECTION 26 0.0008
710 CHOLECYSTECTOMY 9 0.0008
711 NEPHROLITHIASIS 36 0.0008
712 PALPITATIONS 91 0.0008
713 TOOTHACHE 14 0.0008
714 MELAENA 17 0.0008
715 BRAIN FOG 12 0.0008
716 SKIN LESION 21 0.0008
717 DEAFNESS 20 0.0008
718 ANHEDONIA 20 0.0008
719 GASTROOESOPHAGEAL REFLUX DISEASE 61 0.0008
720 LUNG DISORDER 37 0.0008
721 ADVERSE REACTION 10 0.0008
722 MUSCLE RIGIDITY 9 0.0008
723 FEELING HOT 46 0.0007
724 IRRITABLE BOWEL SYNDROME 16 0.0007
725 DRUG EFFECT LESS THAN EXPECTED 11 0.0007
726 BLOOD POTASSIUM INCREASED 12 0.0007
727 FLUSHING 75 0.0007
728 COLD SWEAT 13 0.0007
729 GENERAL PHYSICAL HEALTH DETERIORATION 85 0.0007
730 CHEST PAIN 136 0.0007
731 ILEUS 9 0.0007
732 ABDOMINAL PAIN 168 0.0007
733 MUSCULOSKELETAL CHEST PAIN 11 0.0007
734 CARDIOVASCULAR DISORDER 18 0.0007
735 RENAL DISORDER 33 0.0007
736 WEIGHT DECREASED 197 0.0007
737 EMOTIONAL DISTRESS 85 0.0007
738 EYE DISORDER 23 0.0007
739 OEDEMA PERIPHERAL 85 0.0007
740 PRODUCT PRESCRIBING ISSUE 15 0.0007
741 CAESAREAN SECTION 8 0.0007
742 CHRONIC KIDNEY DISEASE 52 0.0007
743 ADVERSE DRUG REACTION 61 0.0007
744 POST PROCEDURAL COMPLICATION 13 0.0007
745 INCORRECT DRUG ADMINISTRATION DURATION 19 0.0007
746 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 35 0.0007
747 DIZZINESS 334 0.0007
748 BLOOD PRESSURE INCREASED 102 0.0007
749 PHOTOSENSITIVITY REACTION 11 0.0007
750 GAIT DISTURBANCE 127 0.0007
751 LACRIMATION INCREASED 20 0.0007
752 PELVIC PAIN 12 0.0007
753 FIBROMYALGIA 16 0.0007
754 HAEMATOMA 17 0.0007
755 TINNITUS 30 0.0007
756 NAUSEA 514 0.0006
757 DEHYDRATION 86 0.0006
758 NECK PAIN 36 0.0006
759 HAEMATURIA 22 0.0006
760 TOOTH DISORDER 14 0.0006
761 PREMATURE DELIVERY 10 0.0006
762 SCIATICA 10 0.0006
763 GASTROINTESTINAL HAEMORRHAGE 52 0.0006
764 NEURALGIA 15 0.0006
765 CEREBRAL HAEMORRHAGE 22 0.0006
766 PRODUCT USE IN UNAPPROVED INDICATION 151 0.0006
767 BLOOD PRESSURE ABNORMAL 12 0.0006
768 UPPER LIMB FRACTURE 12 0.0006
769 HAEMORRHAGE INTRACRANIAL 9 0.0006
770 PREGNANCY 12 0.0006
771 SPINAL FRACTURE 12 0.0006
772 MYALGIA 101 0.0006
773 MALAISE 259 0.0006
774 OSTEOARTHRITIS 25 0.0006
775 MIGRAINE 56 0.0006
776 GASTRIC ULCER 11 0.0006
777 ASCITES 17 0.0006
778 ACUTE MYOCARDIAL INFARCTION 17 0.0006
779 ABDOMINAL PAIN UPPER 118 0.0006
780 PNEUMONIA 185 0.0006
781 GLAUCOMA 11 0.0006
782 NEUROTOXICITY 10 0.0006
783 MOUTH ULCERATION 12 0.0006
784 ABASIA 14 0.0006
785 ULCER 9 0.0006
786 FLATULENCE 32 0.0006
787 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
788 HYPOAESTHESIA 84 0.0006
789 ILL-DEFINED DISORDER 34 0.0006
790 ASTHENIA 209 0.0006
791 HEADACHE 344 0.0005
792 EPISTAXIS 41 0.0005
793 RENAL INJURY 16 0.0005
794 WEIGHT INCREASED 120 0.0005
795 OEDEMA 29 0.0005
796 HYPOTHYROIDISM 17 0.0005
797 PRODUCT ADHESION ISSUE 19 0.0005
798 BACK PAIN 123 0.0005
799 DYSPEPSIA 52 0.0005
800 ECONOMIC PROBLEM 8 0.0005
801 THROMBOCYTOPENIA 59 0.0005
802 ILLNESS 54 0.0005
803 CARDIAC DISORDER 49 0.0005
804 ANGINA PECTORIS 15 0.0005
805 MUSCLE SPASMS 96 0.0005
806 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 106 0.0005
807 CONSTIPATION 113 0.0005
808 HOT FLUSH 39 0.0005
809 ORTHOSTATIC HYPOTENSION 9 0.0005
810 HAEMORRHAGE 54 0.0005
811 DYSSTASIA 15 0.0005
812 VISUAL ACUITY REDUCED 17 0.0005
813 VIRAL INFECTION 17 0.0005
814 ACTIVITIES OF DAILY LIVING IMPAIRED 10 0.0005
815 BLOOD PRESSURE FLUCTUATION 12 0.0005
816 MOVEMENT DISORDER 16 0.0005
817 VISION BLURRED 67 0.0005
818 THERAPY CESSATION 25 0.0005
819 RASH MACULAR 17 0.0005
820 PRODUCTIVE COUGH 23 0.0005
821 THROAT TIGHTNESS 13 0.0005
822 SWELLING FACE 31 0.0005
823 MYOCARDIAL INFARCTION 83 0.0005
824 KNEE ARTHROPLASTY 10 0.0005
825 HYPOPHAGIA 12 0.0005
826 EXTRA DOSE ADMINISTERED 19 0.0005
827 VISUAL IMPAIRMENT 58 0.0005
828 FAECES DISCOLOURED 10 0.0005
829 DECREASED APPETITE 107 0.0005
830 BLOOD GLUCOSE DECREASED 22 0.0005
831 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 22 0.0005
832 DIABETIC KETOACIDOSIS 11 0.0005
833 DYSPNOEA 259 0.0005
834 SKIN DISCOLOURATION 21 0.0005
835 HOSPITALISATION 70 0.0005
836 SINUS DISORDER 9 0.0005
837 CATARACT 27 0.0005
838 NEUROPATHY PERIPHERAL 43 0.0005
839 MUSCULOSKELETAL STIFFNESS 39 0.0004
840 ERYTHEMA 91 0.0004
841 DRY EYE 22 0.0004
842 C-REACTIVE PROTEIN INCREASED 16 0.0004
843 MUSCULOSKELETAL PAIN 23 0.0004
844 DIABETES MELLITUS 33 0.0004
845 ARTHRITIS 34 0.0004
846 FEELING COLD 12 0.0004
847 CHILLS 50 0.0004
848 CONDITION AGGRAVATED 129 0.0004
849 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
850 HYPOCALCAEMIA 8 0.0004
851 CHEST DISCOMFORT 43 0.0004
852 LIVER FUNCTION TEST INCREASED 9 0.0004
853 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 23 0.0004
854 TYPE 2 DIABETES MELLITUS 14 0.0004
855 FATIGUE 322 0.0004
856 ERUCTATION 8 0.0004
857 CHOKING 8 0.0004
858 CEREBRAL INFARCTION 10 0.0004
859 PAIN 250 0.0004
860 ASTHMA 46 0.0004
861 HAEMATOCRIT DECREASED 8 0.0004
862 HEART RATE IRREGULAR 9 0.0004
863 RECTAL HAEMORRHAGE 17 0.0004
864 COLITIS 15 0.0004
865 SEPTIC SHOCK 17 0.0004
866 PSORIASIS 51 0.0004
867 SINUSITIS 40 0.0004
868 SKIN DISORDER 13 0.0004
869 INFLUENZA LIKE ILLNESS 32 0.0004
870 RHINORRHOEA 25 0.0004
871 SEPSIS 43 0.0004
872 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
873 RED BLOOD CELL COUNT DECREASED 11 0.0004
874 APPLICATION SITE ERYTHEMA 10 0.0004
875 JOINT STIFFNESS 10 0.0004
876 DYSPHAGIA 36 0.0004
877 MUSCULAR WEAKNESS 43 0.0004
878 HYPERSENSITIVITY 70 0.0004
879 LOWER RESPIRATORY TRACT INFECTION 17 0.0004
880 ABDOMINAL DISTENSION 39 0.0004
881 OFF LABEL USE 327 0.0004
882 DRUG EFFECT DECREASED 20 0.0004
883 BURNING SENSATION 26 0.0004
884 RENAL IMPAIRMENT 31 0.0004
885 BLINDNESS 15 0.0004
886 PYREXIA 127 0.0004
887 ANAPHYLACTIC REACTION 20 0.0004
888 EXPIRED PRODUCT ADMINISTERED 12 0.0004
889 DISCOMFORT 22 0.0004
890 DYSPHONIA 21 0.0004
891 HAEMOPTYSIS 10 0.0004
892 DEMENTIA 10 0.0004
893 GASTROINTESTINAL DISORDER 32 0.0004
894 CELLULITIS 18 0.0004
895 LIMB DISCOMFORT 11 0.0004
896 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 25 0.0004
897 BRONCHITIS 26 0.0004
898 GASTRIC DISORDER 12 0.0003
899 PRODUCT DOSE OMISSION ISSUE 102 0.0003
900 HAEMATOCHEZIA 19 0.0003
901 ARTHROPATHY 19 0.0003
902 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 61 0.0003
903 EAR INFECTION 9 0.0003
904 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 24 0.0003
905 EYE PAIN 19 0.0003
906 PULMONARY EMBOLISM 32 0.0003
907 DYSGEUSIA 25 0.0003
908 SKIN EXFOLIATION 28 0.0003
909 DIARRHOEA 212 0.0003
910 COVID-19 57 0.0003
911 DIVERTICULITIS 9 0.0003
912 OROPHARYNGEAL PAIN 30 0.0003
913 CARDIAC FAILURE CONGESTIVE 26 0.0003
914 NASAL CONGESTION 19 0.0003
915 ABDOMINAL DISCOMFORT 54 0.0003
916 DYSPNOEA EXERTIONAL 12 0.0003
917 GLYCOSYLATED HAEMOGLOBIN INCREASED 8 0.0003
918 OSTEOPOROSIS 13 0.0003
919 ARTHRALGIA 131 0.0003
920 NASOPHARYNGITIS 58 0.0003
921 THROAT IRRITATION 14 0.0003
922 INFECTION 45 0.0003
923 LYMPHADENOPATHY 11 0.0003
924 INFLAMMATION 16 0.0003
925 DIPLOPIA 8 0.0003
926 IMPAIRED HEALING 10 0.0003
927 PAIN IN EXTREMITY 89 0.0003
928 LEUKOPENIA 15 0.0003
929 EYE SWELLING 11 0.0003
930 INJECTION SITE RASH 9 0.0003
931 DEEP VEIN THROMBOSIS 19 0.0003
932 INCORRECT DOSE ADMINISTERED 66 0.0003
933 INFLUENZA 32 0.0003
934 SYSTEMIC LUPUS ERYTHEMATOSUS 10 0.0003
935 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
936 THERAPEUTIC RESPONSE DECREASED 17 0.0003
937 EYE IRRITATION 16 0.0003
938 FLUID RETENTION 14 0.0003
939 RASH ERYTHEMATOUS 13 0.0003
940 THERAPEUTIC RESPONSE SHORTENED 9 0.0003
941 INJECTION SITE MASS 10 0.0003
942 URINARY TRACT INFECTION 46 0.0003
943 THERAPEUTIC PRODUCT EFFECT DECREASED 12 0.0003
944 ECZEMA 14 0.0003
945 HAEMOGLOBIN DECREASED 27 0.0003
946 PRURITUS 101 0.0003
947 BLOOD GLUCOSE INCREASED 49 0.0003
948 RASH 112 0.0003
949 SWELLING 24 0.0003
950 BONE PAIN 15 0.0003
951 VAGINAL HAEMORRHAGE 11 0.0003
952 PLATELET COUNT DECREASED 27 0.0003
953 ADVERSE EVENT 23 0.0002
954 DRUG INTOLERANCE 24 0.0002
955 DRY SKIN 33 0.0002
956 PSORIATIC ARTHROPATHY 10 0.0002
957 URTICARIA 41 0.0002
958 NO ADVERSE EVENT 44 0.0002
959 DRUG INEFFECTIVE 318 0.0002
960 ANAEMIA 46 0.0002
961 SKIN IRRITATION 11 0.0002
962 FUNGAL INFECTION 8 0.0002
963 INTESTINAL OBSTRUCTION 9 0.0002
964 PANCYTOPENIA 13 0.0002
965 COUGH 65 0.0002
966 BLISTER 13 0.0002
967 INJECTION SITE ERYTHEMA 27 0.0002
968 TREATMENT FAILURE 18 0.0002
969 CEREBROVASCULAR ACCIDENT 36 0.0002
970 THROMBOSIS 17 0.0002
971 MULTIPLE SCLEROSIS 10 0.0002
972 HERPES ZOSTER 12 0.0002
973 PRODUCT QUALITY ISSUE 28 0.0002
974 INJECTION SITE HAEMORRHAGE 16 0.0002
975 THERAPY NON-RESPONDER 9 0.0002
976 DISEASE RECURRENCE 9 0.0002
977 WHEEZING 11 0.0002
978 RASH PRURITIC 10 0.0002
979 PERIPHERAL SWELLING 28 0.0002
980 SKIN BURNING SENSATION 13 0.0002
981 DRUG DOSE OMISSION 28 0.0002
982 ALOPECIA 33 0.0002
983 BREAST CANCER 15 0.0002
984 WHITE BLOOD CELL COUNT DECREASED 17 0.0002
985 INJECTION SITE PRURITUS 10 0.0001
986 INJECTION SITE BRUISING 11 0.0001
987 NEOPLASM MALIGNANT 9 0.0001
988 JOINT SWELLING 16 0.0001
989 RHEUMATOID ARTHRITIS 15 0.0001
990 ACNE 10 0.0001
991 INJECTION SITE PAIN 40 0.0001
992 THERAPY INTERRUPTED 9 0.0001
993 INJECTION SITE SWELLING 9 0.0001
994 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
995 NEUTROPENIA 12 0.0001